Medicare caregiver support program yields better outcomes than Alzheimer’s medication alone, study finds

Patients with dementia who participated in a Medicare-funded collaborative care program that provided support and medical advice for caregivers were able to remain in their home communities longer before entering nursing homes, according to a new study. This compares to those patients who were taking lecanemab, one of two approved drugs that have been shown to slow progression of Alzheimer’s in some patients, a February study published in Alzheimer’s & Dementia: Behavior & Socioeconomics of Aging found. 

Improving brain blood flow in Alzheimer’s disease is focus of UM researchers’ study: “Major stepping stone”

In a new study that could have significant implications for future Alzheimer’s treatmentresearchers at the University of Miami have successfully figured out how to combat one of the early signs of the neurodegenerative disease.

In the study published in the Journal of the Alzheimer’s Association in December 2025 — “Systemic Piezo1 activation improves cerebrovascular function in Alzheimer’s disease

Read the study HERE

Alzheimer’s scrambles memories while the brain rests

New findings reveal a subtle but powerful breakdown that may help explain early memory loss in Alzheimer’s.

When the brain rests, it usually replays recent experiences to strengthen memory. Scientists found that in Alzheimer’s-like mice, this replay still occurs — but the signals are jumbled and poorly coordinated. As a result, memory-supporting brain cells lose their stability, and the animals struggle to remember where they’ve been.

Read it all HERE

Scientists Uncover a Hidden Early Stage of Alzheimer’s That They Can Stop

Scientists at Tokyo Metropolitan University have turned to polymer physics to better understand one of the defining features of Alzheimer’s disease: the formation of tau protein fibrils. Their research shows that these fibrils do not form directly. Instead, tau proteins first gather into large clusters, similar to how polymers begin to crystallize. When researchers disrupted these early clusters, fibrils failed to develop in solution.

This finding points to a major shift in how future treatments for neurodegenerative diseases might be designed.

Read the article HERE